Volex Plc (VLX)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 563.00 |
|---|---|
| 52-week range | 357.83 – 706.01 |
| Return, 1 month / 3 months | −8.2% / +8.9% |
| Return, 1 year / 3 years | +55.8% / +109.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 31 |
| Volatility (1 year) | 43.1% |
| Worst drawdown (1 year) | -28.6% |
| Average daily value traded | 606.16M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Volex is a manufacturer of power cords, cable assemblies and electrical connectors. It supplies these components to makers of consumer electronics, appliances, industrial equipment and data and medical devices, working with original equipment manufacturers and their suppliers. The company is based in the United Kingdom and operates manufacturing sites in several countries, serving customers across Europe, Asia and North America with cable and connectivity products built to their specifications.
On this site Volex Plc appears as a stock on the London Exchange (UK), code VLX, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Volex Plc (VLX) trades on the London Exchange in UK. It last closed at GBX 563.00 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,093 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 55.8% and over the last three months it rose 8.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.0% | ||
| From 52-week high | -19.5% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.9% | ||
| 6-month return | -2.0% | ||
| 12-month return, skipping the last month | 69.6% | ||
| Risk (lower is better) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 43.1% | ||
| Worst drawdown (1 year) | -28.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 606.16M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −17.7% |
|---|---|
| 1 month | −8.2% |
| 3 months | +8.9% |
| 6 months | −2.0% |
| 1 year | +55.8% |
| 3 years | +109.4% |
| 5 years | +35.5% |
Signals
| 50-day / 200-day average | 615.17 / 546.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 28.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0320 |
| 27 Nov 2025 | GBP 0.0160 |
| 31 Jul 2025 | GBP 0.0300 |
| 28 Nov 2024 | GBP 0.0150 |
| 25 Jul 2024 | GBP 0.0280 |
| 30 Nov 2023 | GBP 0.0140 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.